对于长期透析中心房的患者,进行最佳的血栓塞栓预防
Kenji Hashimoto1, Tomohiro Fujisaki2,3, Tadao Aikawa4
1Westmead Applied Research Centre, University of Sydney, Sydney, New South Wales, Australia.
Pacing and clinical electrophysiology : PACE
|June 5, 2025
概括
对于透析中的心房 (AF) 患者来说,左心房尾闭塞 (LAAO) 显示出有望预防血栓栓塞. 某些直接口服抗凝剂 (DOAC),如利瓦洛克萨班和阿皮克萨班,也提供了有利的安全性和有效性.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在透析中的心房动 (AF) 患者中,血栓塞栓的预防能力不足.
- 现有的策略,如维生素K对抗剂 (VKA) 和直接口服抗凝剂 (DOAC),需要在这个人群中进一步研究.
- 左心房尾阻塞 (LAAO) 是一个新兴的替代方案.
研究的目的:
- 进行一个网络元分析,比较在透析的AF患者中血栓栓塞预防策略的有效性和安全性.
- 为这个高风险群体确定最佳的治疗选择.
主要方法:
- 在2024年1月之前,对多个数据库进行了全面的搜索.
- 主要终点包括血栓事件 (缺血性中风,全身血栓栓塞) 和严重出血.
- 策略使用P-score进行排名.
主要成果:
- 分析包括28项研究,其中144,630名透析的AF患者.
- DOACs和VKA显示了与没有抗凝固药物治疗相比的血栓事件风险.
- 在LAAO中,血栓事件的风险显著降低 (HR [95% CI]:0.19 [0.06-0.60]).
- 与没有抗凝剂相比,VKA,常规剂量里瓦洛克萨班和达比加特兰增加了重大出血风险.
- 利瓦洛克萨班每天10毫克和阿皮克萨班每天两次2.5或5毫克并没有增加重大出血风险.
- 拉奥,利瓦洛克萨班每天10毫克,阿皮克萨班每天两次2.5或5毫克在有效性和安全性方面排名高.
结论:
- 对于透析的AF患者来说,LAAO可能是一个合适的治疗选择.
- 低剂量里瓦洛克萨班 (每天10毫克) 和特定的阿皮克萨班剂量 (每天两次2.5或5毫克) 也是相当大的选择.
- 需要进一步的研究来验证这些发现.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Hemodialysis I: Introduction
311
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
311
Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
48
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
48
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27


